EGFR and lung carcinoma: The EGF-receptor (EGFR) has become an important target in clinical oncology, and EGFR-targeting kinase inhibitors and monoclonal antibodies are routinely used in the treatment of lung cancer, head and neck cancer, and colorectal cancer (Guardiola et al., 2019).